Treatment of HIV infection with a raltegravir-based regimen increases LDL levels, but improves HDL cholesterol efflux capacity

BACKGROUND: Persons infected with HIV often have altered lipid profiles that may be affected by antiretroviral therapies (ART). Traditional lipid measurements may be insufficient to assess cardiovascular disease (CVD) risk in this population. METHODS: We report results from 39 ART-naive participants...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antivir Ther
Hlavní autoři: Funderburg, Nicholas T, Xu, Dihua, Playford, Martin P, Joshi, Aditya A, Andrade, Adriana, Kuritzkes, Daniel R, Lederman, Michael M, Mehta, Nehal N
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516727/
https://ncbi.nlm.nih.gov/pubmed/27740536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3851/IMP3091
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky